Trademark: 90642345
Word
ALKERMES INSPIRATION GRANTS
Status Date
Tuesday, July 12, 2022
Registration Number
6791237
Registration Date
Tuesday, July 12, 2022
Filing Date
Tuesday, April 13, 2021
Published for Opposition
Tuesday, January 11, 2022
36 Providing grants to organizations dedicated to patient focused medical research; funding service awards, namely, providing grants to patient advocacy groups and institutions for the treatment and management of diseases including, but not limited to, addiction and central nervous system disorders
The mark consists of the stylized wording "ALKERMES" with an incomplete circle appearing to the left and around the letter "A". The stylized wording "INSPIRATION GRANTS" appears beneath the wording "ALKERMES", and a stylized person appears to the right of the wording "INSPIRATION GRANTS". The torso, left arm, and left leg of the stylized person consists of a right facing arrow.
"GRANTS"
Jul 12, 2022
Notice Of Registration Confirmation Emailed
Jul 12, 2022
Registered-Principal Register
Jun 4, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 3, 2022
Allowed Principal Register - Sou Accepted
Jun 1, 2022
Statement Of Use Processing Complete
May 16, 2022
Use Amendment Filed
Jun 1, 2022
Case Assigned To Intent To Use Paralegal
May 16, 2022
Teas Statement Of Use Received
Mar 8, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 11, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 11, 2022
Published For Opposition
Dec 22, 2021
Notification Of Notice Of Publication E-Mailed
Dec 3, 2021
Assigned To Lie
Dec 3, 2021
Approved For Pub - Principal Register
Dec 3, 2021
Examiner's Amendment Entered
Dec 3, 2021
Notification Of Examiners Amendment E-Mailed
Dec 3, 2021
Examiners Amendment E-Mailed
Dec 3, 2021
Examiners Amendment -Written
Dec 3, 2021
Assigned To Examiner
Jul 21, 2021
Notice Of Design Search Code E-Mailed
Jul 20, 2021
New Application Office Supplied Data Entered In Tram
Apr 16, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
